Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × ALK1-Fc fusion protein, human × Clear all

NCT01720173 2021-10-20

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Phase 2 Completed

30 enrolled 10 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms